A stepwise clinical approach
International menopause guidance emphasizes identifying reversible contributors first. Vaginal estrogen or moisturizers for dyspareunia, treating depression/anxiety, reviewing medications (e.g., some SSRIs), and counseling are core steps.
Transdermal testosterone has evidence for postmenopausal HSDD in carefully selected women, with monitoring for androgenic side effects. Compounded pellets lack the same regulatory evidence base and are not part of HormoneFit’s approach.